Forty-two million people worldwide are infected with HIV, and the vast majority of them live in the developing world, with little access to sophisticated labs that can monitor their immune-cell levels-measurements critical to determining their need for and response to drugs. Researchers from the University of Texas at Austin and Boston’s Massachusetts General Hospital are developing a portable immune-cell reader to fill this gap. At the heart of the device is a microchip that filters white blood cells out of a few drops of blood and stains the key ones red, green, and yellow. A digital camera then takes a picture of the cells, which software analyzes to determine the counts of each cell type, indicating how well the immune system is holding up. Though the current prototype is the size of a desktop computer, the researchers aim to produce a handheld version within the year. Ultimately, they hope each test will cost less than $3, compared to the $35 to $60 charged by conventional labs. Early trials of the system conducted in Boston and Botswana have been encouraging. The researchers say testers in Botswana liked the prototype so much they didn’t want to send it back.
How AI is reinventing what computers are
Three key ways artificial intelligence is changing what it means to compute.
These weird virtual creatures evolve their bodies to solve problems
They show how intelligence and body plans are closely linked—and could unlock AI for robots.
We reviewed three at-home covid tests. The results were mixed.
Over-the-counter coronavirus tests are finally available in the US. Some are more accurate and easier to use than others.
A horrifying new AI app swaps women into porn videos with a click
Deepfake researchers have long feared the day this would arrive.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.